Skip to main content

Table 1 Demographic characteristics of the study subjects

From: Tamoxifen use reduces the risk of osteoporotic fractures in women with breast cancer in Asia: a nationwide population-based cohort study

 

All N = 75488

With tamoxifen N = 50257

Without tamoxifen N = 25231

 

Variable

n

%

n

%

n

%

p-value

Age, years

      

<0.0001

<50

35715

47.3

25778

51.3

9937

39.4

 

50-59

21676

28.7

13124

26.1

8552

33.9

 

60-69

11353

15.0

7001

13.9

4352

17.6

 

70+

6744

8.93

4354

8.66

2390

9.47

 

Urbanization

      

0.34

Urban

50793

67.3

33874

67.4

16919

67.1

 

Rural

24695

32.7

16383

32.6

8312

32.9

 

Month income, NTD

      

<0.0001

<= 15000

12795

17.0

8231

16.4

4564

18.1

 

15001-20000

39463

52.3

26326

52.4

13137

52.1

 

>20000

33230

30.8

15700

31.2

7530

29.8

 

Comorbidity

       

Hypertension

21882

29.0

14142

28.1

7740

30.7

<0.0001

Hyperlipidemia

15458

20.5

9952

19.8

5506

21.8

<0.0001

Diabetes

8948

11.9

5698

11.3

3250

12.9

<0.0001

PAD

1477

1.96

905

1.80

572

2.27

<0.0001

Stroke

1715

2.27

1012

2.01

703

2.79

<0.0001

Osteoporosis

8024

10.6

5114

10.2

2910

11.5

<0.0001

Medicine, n (%)

       

HRT used before the index date

36690

48.6

24487

48.7

12203

48.4

0.35

Aromatase inhibitors used before the end point

20507

27.2

16273

32.4

4234

16.8

<0.0001

  1. Chi-square test
  2. PAD, peripheral artery disease